This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beckman Corporation. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Inventor Spotlight: Susan J Berners-Price
Introduction:
Susan J Berners-Price is a pioneering inventor hailing from South Croydon, GB, known for her groundbreaking work in the field of pharmaceutical compositions aimed at inhibiting tumor cell growth. With a keen intellect and a passion for innovation, Susan has made significant contributions to the medical field through her patented inventions.
Latest Patents:
Susan J Berners-Price holds a notable patent for tumor cell growth-inhibiting pharmaceutical compositions. Her patent involves the use of bis[bis(diphenylphosphino)hydrocarbon]-, bis[bis(diethylphosphino)hydrocarbon]-, bis[bis(diphenylphosphine-deithylphosphino)hydrocarbon]gold(I), silver(I) or copper(I) complex, or a tris[bis(diphenylphosphino)ethane] dicopper(I) complex to inhibit the growth of tumor cells in animals.
Career Highlights:
Susan is affiliated with the SmithKline Beckman Corporation, a renowned pharmaceutical company. Her dedication to research and development has led to the creation of innovative pharmaceutical compositions aimed at combatting cancer and improving patient outcomes. Susan's work exemplifies the intersection of science and creativity in finding solutions to complex medical challenges.
Collaborations:
Throughout her career, Susan has collaborated with esteemed colleagues such as Randall K Johnson and Christopher K Mirabelli. Together, they have worked synergistically to advance the field of oncology and develop novel approaches to treating tumor cells. Susan's collaborative spirit and teamwork have been instrumental in her success as an inventor.
Conclusion:
In conclusion, Susan J Berners-Price stands as a trailblazing inventor whose work has had a profound impact on the medical community. Her pioneering research in tumor cell growth-inhibiting pharmaceutical compositions showcases her dedication to innovation and improving healthcare outcomes. Susan's contributions serve as a testament to the power of ingenuity and perseverance in driving progress within the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile